Uruguay Social Security Deficit Down

15 September 1996

Uruguay's social security deficit in first-half 1996 fell 35% to $646 million over first-half 1995, but was short of the target envisaged in the 1996 economic program agreed with the International Monetary Fund.

The figures reflect costs of recent reforms, including payments for retirement of government officials, etc. However, changes in health service administration and funding have created tensions with some sectors of the medical profession, especially doctors working in the cardiovascular institutes. The sector association, the AMIC, has expressed concern and anger at a meeting with the Senate Health Commission over the "bankrupt situation" in cardiovascular medicine because, it claims, of "illegal decisions" adopted at the behest of the Health Ministry.

AMIC delegation leader Walter Espasandin said reforms introduced by Health Minister Alfredo Solari, notably curbs on services, had led to a system which was an example and a source of pride having "totally disappeared." A spokesman for the heart surgeons said a health care system had disappeared which over 15 years had provided "a definitive solution for a high percentage of people" requiring advanced treatment. Funding cuts have led to higher mortality, the doctors claim.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight